NextFerm expands North American distribution of astaxanthin gummies to Canadian market

Image courtesy of NextFerm

NextFerm (Yokneam Illit, Israel) announced the first commercial sales of Astaferm astaxanthin gummies in the Canadian market to Grand Health after receiving a Natural Product Number from the country.

“We’re very happy from the progression we’re making in North America for Astaferm in its various forms,” said Elzaphan Hotam, CEO of NextFerm USA, in a press release. “We continue to see sales with our existing customers as well as increased interest and understanding of what we do by leading brands and large distributors. Expanding into the Canadian territory is another important step forward. We are also getting ready to increase the level and depth of our strategic collaborations in North America, as the basic advantages in efficiency, potency, flavor and physical performance of our fermented astaxanthin are becoming increasingly clear to the players in the market”

“We are excited to take Astaferm gummies to be part of our product line,” added Raymond Lin CEO of Grand Health. “We loved the flavor, the potency, and the concept of fermented astaxanthin is exactly what we’re looking for in products. It took us a while to register the product in Canada but it paid off. We’re just happy to be the first Canadians that do that”